{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:40:12Z","timestamp":1773268812461,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chemotherapy resistance is the main obstacle to breast cancer recurrence, metastasis, and mortality. Drug-tolerant persister (DTP) cells are a novel type of target cell associated with tumor resistance, and autophagy is a key factor in maintaining the survival of tumor DTP cells. However, it is unclear whether the activation of autophagy in breast cancer DTP cells is related to their overexpression of the transcriptional regulatory factor CDCA7.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analyzed CDCA7 expression using public datasets and clinical samples and established breast cancer cell lines with CDCA7 overexpression and knockdown to assess the role of CDCA7 in breast cancer. Autophagy was assessed via electron microscopy, mRFP-GFP-LC3 imaging, and immunoblotting. Mechanistic studies employed ChIP-seq, dual-luciferase assays, and site-directed mutagenesis. Functional assays measured chemosensitivity (CCK-8), migration\/invasion (scratch\/Transwell), and\n                      <jats:italic>in vivo<\/jats:italic>\n                      tumorigenicity (mouse xenograft).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CDCA7 was significantly upregulated in breast cancer DTP cells. Overexpression of CDCA7 in breast cancer cells significantly enhanced autophagy-related biological processes and molecular functions. Through ChIP-seq and targeted knockout experiments, we identified the binding sites of CDCA7 on the autophagy-related protein genes\n                      <jats:italic>ULK1<\/jats:italic>\n                      ,\n                      <jats:italic>ATG2A<\/jats:italic>\n                      , and\n                      <jats:italic>ATG3<\/jats:italic>\n                      . Using transmission electron microscopy and mRFP\/mCherry-GFP-LC3B tandem fluorescent tagging, we observed that\n                      <jats:italic>CDCA7<\/jats:italic>\n                      knockdown significantly reduced the number of autolysosomes in breast cancer DTP cells and markedly inhibited autophagic flux. Moreover,\n                      <jats:italic>CDCA7<\/jats:italic>\n                      knockdown not only decreased drug resistance in breast cancer cells but also reduced metastasis, invasion, and tumorigenic ability\n                      <jats:italic>in vivo<\/jats:italic>\n                      , ultimately prolonging the survival of tumor-bearing mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CDCA7 drives breast cancer chemoresistance by transcriptionally activating a pro-survival autophagy program in DTP cells, nominating it as a promising therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1782047","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:52:35Z","timestamp":1773211955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CDCA7 promotes chemoresistance of drug-tolerant persister cells in breast cancer by upregulating the expression of autophagy-related protein genes"],"prefix":"10.3389","volume":"17","author":[{"given":"Jin","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Ma","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Southwest Cancer Center, Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Li","sequence":"additional","affiliation":[{"name":"The Biobank of Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Biobank of Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingya","family":"Miao","sequence":"additional","affiliation":[{"name":"The Biobank of Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqiu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Southwest Hospital, the First Affiliated Hospital of the Army Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge","volume":"8","author":"Nedeljkovi\u0107","year":"2019","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108800","article-title":"Chemoresistance mechanisms of breast cancer and their countermeasures","volume":"114","author":"Ji","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1061186X.2025.2550589","article-title":"Combating chemoresistance in breast cancer: exploring tumour microenvironment, combination therapies and drug repurposing strategies","volume":"1","author":"Sofi","year":"2025","journal-title":"J Drug Targeting"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02187-1","article-title":"APOBEC3 mutagenesis drives therapy resistance in breast cancer","volume":"57","author":"Gupta","year":"2025","journal-title":"Nat Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02180-4","article-title":"Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs","volume":"10","author":"Gremke","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000004424","article-title":"Breaking the shields of resistance: multidimensional therapeutic strategies in the breast cancer drug resistance conundrum","volume":"11","author":"Li","year":"2025","journal-title":"Int J Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41571-023-00815-5","article-title":"Drug-tolerant persister cells in cancer: the cutting edges and future directions","volume":"20","author":"Pu","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-024-01891-4","article-title":"Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.11.018","article-title":"Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy","volume":"184","author":"Rehman","year":"2021","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist Updat"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216307","article-title":"Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence","volume":"570","author":"Qin","year":"2023","journal-title":"Cancer Lett"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2258052","article-title":"CENPN suppresses autophagy and increases paclitaxel resistance in nasopharyngeal carcinoma cells by inhibiting the CREB-VAMP8 signaling axis","volume":"20","author":"Wang","year":"2024","journal-title":"Autophagy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2207257","DOI":"10.1002\/advs.202207257","article-title":"Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy","volume":"10","author":"Jiang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2025.2477443","article-title":"HMBOX1 reverses autophagy mediated 5-fluorouracil resistance through promoting HACE1-induced ubiquitination and degradation of ATG5 in colorectal cancer","volume":"21","author":"Gao","year":"2025","journal-title":"Autophagy"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0536","article-title":"The Myc target gene JPO1\/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity","volume":"65","author":"Osthus","year":"2005","journal-title":"vivo. Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/genes14071406","article-title":"High expression of CDCA7 in the prognosis of glioma and its relationship with ferroptosis and immunity","volume":"14","author":"Wang","year":"2023","journal-title":"Genes (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/mmr.2020.11089","article-title":"High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer","volume":"22","author":"Li","year":"2020","journal-title":"Mol Med Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/cas.15560","article-title":"CDCA7 promotes TGF-\u03b2-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4\/Smad7 in ESCC","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1773","article-title":"CDCA7-regulated inflammatory mechanism through TLR4\/NF-\u03baB signaling pathway in stomach adenocarcinoma","volume":"47","author":"Guo","year":"2021","journal-title":"Biofactors"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1965441","article-title":"Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression","volume":"12","author":"Cai","year":"2021","journal-title":"Bioengineered"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31766","article-title":"Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer","volume":"143","author":"Ye","year":"2018","journal-title":"Int J Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01047-6","article-title":"H3K27me3 conditions chemotolerance in triple-negative breast cancer","volume":"54","author":"Marsolier","year":"2022","journal-title":"Nat Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-8-91","article-title":"An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol","volume":"8","author":"Liu","year":"2008","journal-title":"BMC Biotechnol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"eaax5819","DOI":"10.1126\/sciadv.aax5819","article-title":"CHK2-FOXK axis promotes transcriptional control of autophagy programs","volume":"6","author":"Chen","year":"2020","journal-title":"Sci Adv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12943-024-02217-2","article-title":"Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance","volume":"24","author":"Zhao","year":"2025","journal-title":"Mol Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116047","article-title":"TP53R175H mutation promotes breast cancer cell proliferation through CORO1A-P38 MAPK pathway regulation","volume":"221","author":"Su","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06637-w","article-title":"PIK3CA-mutations in breast cancer","volume":"196","author":"Reinhardt","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16033","article-title":"BRCA1\/2 reversion mutations in a pan-cancer cohort","volume":"115","author":"Nakamura","year":"2024","journal-title":"Cancer Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbaexp.2006.02.004","article-title":"JPO1\/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity","volume":"1759","author":"Goto","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1304","article-title":"Modulated termination of non-coding transcription partakes in the regulation of gene expression","volume":"50","author":"Haidara","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-024-01322-6","article-title":"MYC phase separation selectively modulates the transcriptome","volume":"31","author":"Yang","year":"2024","journal-title":"Nat Struct Mol Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110626","article-title":"CTCF functions as an insulator for somatic genes and a chromatin remodeler for pluripotency genes during reprogramming","volume":"39","author":"Song","year":"2022","journal-title":"Cell Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209080","article-title":"Transcription factor YY1: structure, function, and therapeutic implications in cancer biology","volume":"25","author":"Gordon","year":"2006","journal-title":"Oncogene"},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbcan.2019.04.003","article-title":"The AP-1 transcriptional complex: Local switch or remote command","volume":"1872","author":"Bejjani","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41419-025-07399-1","article-title":"CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance","volume":"16","author":"Zheng","year":"2025","journal-title":"Cell Death Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1563869","article-title":"CircASH1L inhibits ferroptosis and enhances cisplatin resistance by sponging miR-515-5p to regulate cell cycle-related CDCA7\/RRM2 in ovarian cancer cells","volume":"16","author":"Feng","year":"2025","journal-title":"Front Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13046-024-03085-w","article-title":"Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy","volume":"43","author":"Zheng","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217836","article-title":"Targeting autophagy in breast cancer","volume":"21","author":"Cocco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.103279","article-title":"The dual role of autophagy in breast cancer stemness and treatment resistance","volume":"99","author":"Panicker","year":"2026","journal-title":"Tissue Cell"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081156","article-title":"Autophagy and breast cancer: connected in growth, progression, and therapy","volume":"12","author":"Wu","year":"2023","journal-title":"Cells"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1782047\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:52:36Z","timestamp":1773211956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1782047\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2026.1782047"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1782047","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1782047"}}